. Author manuscript; available in PMC: 2022 Sep 1.

Published in final edited form as: Eur J Endocrinol. 2022 Jul 25;187(3):429–437. doi: 10.1530/EJE-22-0285

Table 2:

Presentation and outcomes of patients with abnormal preoperative overnight dexamethasone suppression test.

Patient	Year of evaluation	Post 1-mg DST cortisol (nmol/L)	Baseline ACTH (pmol/L)	Baseline DHEA-S (nmol/L)	24-hour UFC (nmol/day)	Histopathology	Postoperative adrenal insufficiency
1	2003	66	-	-	-	-	-
2	2011	69	-	-	-	Pseudocyst (hemorrhagic)	No
3	2012	85.5	-	-	14.1	Pseudocyst (hemorrhagic)	No
4	2017	143.5	2.9	4855.5	151.8	Endothelial cyst	Yes
5^*	2021	149	<1.1	184.8	-	Pseudocyst (hemorrhagic)	Yes

Abbreviations used: . ACTH = adrenocorticotrophic hormone or corticotropin. DHEA-S = dehydroepiandrosterone sulfate. DST = dexamethasone suppression test; UFC, urinary free cortisol.

Reference range – Baseline ACTH 1.6–13.9 pmol/L. DHEA-S 1793–9214.4 nmol/L. Post DST cortisol ≤50 nmol/L. Urine free cortisol 9.7–127.2nmol/day

Patient on long-term prednisone therapy for rheumatoid arthritis and polymyalgia rheumatica